Tw. Vanderah et al., Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance, J NEUROSC, 21(1), 2001, pp. 279-286
Many clinical case reports have suggested that sustained opioid exposure ca
n elicit unexpected, paradoxical pain. Here, we explore the possibility tha
t (1) opioid-induced pain results from tonic activation of descending pain
facilitation arising in the rostral ventromedial medulla (RVM) and (2) the
presence of such pain manifests behaviorally as antinociceptive tolerance.
Rats implanted subcutaneously with pellets or osmotic minipumps delivering
morphine displayed time-related tactile allodynia and thermal hyperalgesia
(i.e., opioid-induced "pain"); placebo pellets or saline minipumps did not
change thresholds. Opioid-induced pain was observed while morphine delivery
continued and while the rats were not in withdrawal. RVM lidocaine, or bil
ateral lesions of the dorsolateral funiculus (DLF), did not change response
thresholds in placebo-pelleted rats but blocked opioid-induced pain. The i
ntrathecal morphine antinociceptive dose-response curve (DRC) in morphine-p
elleted rats was displaced to the right of that in placebo-pelleted rats, i
ndicating antinociceptive "tolerance." RVM lidocaine or bilateral DLF lesio
n did not alter the intrathecal morphine DRC in placebo-pelleted rats but b
locked the rightward displacement seen in morphine-pelleted animals. The su
bcutaneous morphine antinociceptive DRC in morphine-pelleted rats was displ
aced to the right of that in placebo-pelleted rats; this right shift was bl
ocked by RVM lidocaine. The data show that (1) opioids elicit pain through
tonic activation of bulbospinal facilitation from the RVM, (2) increased pa
in decreases spinal opioid antinociceptive potency, and (3) blockade of pai
n restores antinociceptive potency, revealing no change in antinociceptive
signal transduction. These studies offer a mechanism for paradoxical opioid
-induced pain and allow the development of approaches by which the loss of
analgesic activity of opioids might be inhibited.